The story of Viagra and its influence on the pharmaceutical sector presents escort a challenging question regarding its continued viability as an investment. Initially a blockbuster success, generating billions , generic competition has substantially eroded profit margins . While major pharmaceutical firms hold patents on related therapies and expl
Sildenafil and its Maker and Big Pharma: A Dangerous Investment?
The performance of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key territories has introduced considerable uncertainty . Investors are now grappling with the effect o